ArticleAnnals of nuclear medicine2026
Quantitative analysis of striatal subregional asymmetry on
Article in Annals of nuclear medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The radiotracer [Annals of nuclear medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveTo investigate the relationship between striatal asymmetry indices-namely the High/Low Ratio and Asymmetry Index (AI)-derived from dopamine transporter single-photon emission computed tomography (DAT-SPECT) using
methodsFifty-six patients with clinically diagnosed PD underwent
resultsPutaminal asymmetry was significantly greater in early-stage PD patients (Hoehn-Yahr ≤ 2; p = 0.010), suggesting early lateralized dopaminergic degeneration. The AI of the caudate nucleus was strongly correlated with UPDRS Part I (non-motor symptoms; r = 0.690, p < 0.001), while putaminal asymmetry was significantly associated with UPDRS Part III (motor symptoms; r = 0.497, p < 0.001).
conclusionRegion-specific DAT-SPECT asymmetry shows domain-specific correlations in PD (caudate-non-motor; putamen-motor). These findings may support the use of TRODAT-1-based imaging biomarkers for precision assessment and individualized management; however, they are hypothesis-generating and require confirmation in larger, better-balanced prospective cohorts.
Indexed as
Identifiers
41032219What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.